The latest quarterly R&D expense is $19.03 Million with a QoQ Growth of +21.17%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $19.03M.
$19.03M
$19.03 Million
Q2 FY2026 · 2026-06-30
+21.17%
vs. $15.70M prior quarter
18
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $19.03M | +21.17% | +29.25% |
| Q1 FY2026Period end 2026-03-31 | $15.70M | -3.13% | -8.55% |
| Q4 FY2025Period end 2025-12-31 | $16.21M | +3.28% | -11.74% |
| Q3 FY2025Period end 2025-09-30 | $15.70M | +6.62% | -32.99% |
| Q2 FY2025Period end 2025-06-30 | $14.72M | -14.27% | -11.11% |
| Q1 FY2025Period end 2025-03-31 | $17.17M | -6.51% | +9.08% |
| Q4 FY2024Period end 2024-12-31 | $18.37M | -21.59% | +123.70% |
| Q3 FY2024Period end 2024-09-30 | $23.42M | +41.44% | +35.82% |
| Q2 FY2024Period end 2024-06-30 | $16.56M | +5.20% | +47.38% |
| Q1 FY2024Period end 2024-03-31 | $15.74M | +91.74% | -4.23% |
| Q4 FY2023Period end 2023-12-31 | $8.21M | -52.39% | -27.90% |
| Q3 FY2023Period end 2023-09-30 | $17.25M | +53.49% | +12.26% |
| Q2 FY2023Period end 2023-06-30 | $11.24M | -31.65% | -8.40% |
| Q1 FY2023Period end 2023-03-31 | $16.44M | +44.36% | +62.01% |
| Q4 FY2022Period end 2022-12-31 | $11.39M | -25.88% | N/A |
| Q3 FY2022Period end 2022-09-30 | $15.36M | +25.23% | N/A |
| Q2 FY2022Period end 2022-06-30 | $12.27M | +20.90% | N/A |
| Q1 FY2022Period end 2022-03-31 | $10.15M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
